When: Confirmed close <$91 with expanding MACD negative, OR Q4 FY26 miss ≥10% with guidance cut, OR confirmed death cross

Then: Downgrade to Sell

REDUCE EXPOSURE (15-25% trim at current levels, tightened stop at 98)

• Technical setup shows coiling price action: ATR compressing at 1.99 from 2.57 six weeks ago, RSI at 34.31 defending Bollinger lower band at 91.69, MACD histogram turning positive after six weeks of negatives
• Conservative analyst disagrees with aggressive call to sell into 96-98 resistance zone, arguing price is likely to deliver a tactical bounce rather than reverse immediately
• Macro thesis conflates high-probability bad-news regime with guaranteed outcome; 96% consensus pricing of no cuts in 2026 creates asymmetric risk to dovish surprises that would trigger relief rallies
• Forward EPS of 3.12 reflects 80% recovery supported by Q3 FY26 operating income of 1.2 billion dollars up from 802 million, plus 3 billion dollars of net debt repaid in first three quarters of fiscal 2026
• Dividend consuming 113% of FCF and negative book equity of negative 8.1 billion are real concerns but not immediate triggers; 14 consecutive years of dividend growth argues against imminent cut
• Net debt to EBITDA at 2.67 times is elevated but refinancing is not acute given investment-grade credit, laddered debt stack, and 3.2 billion in cash on hand
• Trade structure flaws: entry at 97.5 requires 3.2% rally first, stop at 102 is 4.6% above entry, target of 88-90 is 7.7-9.7% below entry requiring three sequential outcomes to align
• Aggressive trim at 30-50% would mean selling 15% above 52-week low before any turnaround evidence, creating risk of selling low and buying back high if stopped out at 102
• Recommended action: 15-25% trim executed near current levels around 94-95, stop on remaining position tightened to 98 at the 200 SMA, re-entry possible if price retests and breaks 200 SMA with conviction

→ vs aggressive: Entry at 97.5 requires price to rally 3.2% first before selling, meaning not getting filled today but on a rally into resistance - a low-probability execution path

→ vs aggressive: Target of 88-90 requires three sequential outcomes: rally into resistance, rejection, then trend lower - probability of all three aligning is materially lower than 2:1 headline suggests

→ vs aggressive: Stop at 102 means if stopped out, trader has sold at 94.43 and bought back at 102 - the exact outcome conservative risk management prevents

→ vs aggressive: Specific 22-24 multiple target has no factual basis - it is a feel, not a derived forecast

→ vs aggressive: Consensus already pricing 96% odds of no cuts means asymmetry runs the other way - any dovish surprise creates violent relief rally in long-duration names

→ vs aggressive: Calling forward EPS of 3.12 phantom is analyst malpractice when Q3 operating income is actively improving and management is executing deleveraging

→ vs aggressive: Dividend not a ticking time bomb over 6-12 month horizon given 14 consecutive years of growth, deliberate management choice to suspend buybacks and sell assets to preserve dividend

→ vs aggressive: Refinancing risk on 26.6 billion in debt is real but not acute for investment-grade issuer with laddered debt and 3.2 billion cash

TRIM 20-30% of position; maintain 50-60% core; scale out across 94-97 range; hard stop at 98 on residual; hold through October catalyst calendar

• Technical structure broken: price below all three major moving averages, 200 SMA at 97.94 violated on closing basis
• Momentum positive: MACD histogram flipped positive after six weeks negative, RSI at 34.31 above lower Bollinger Band at 91.69
• Volatility contracting: ATR compressing from 2.57 to 1.99 indicates coiling, not collapse
• Support defended: buyers have held lower band on every test since September 21st
• Macro asymmetric: 10-year yields at 2002 highs with Fed priced at 96% odds of no cuts in 2026; asymmetric risk now to dovish side
• Aggressive multiple compression target of 68-75 (22-24x vs 30x) lacks factual anchor—requires yields at multi-decade highs indefinitely
• Conservative EPS thesis: 3.12 forward EPS is analyst consensus, not company guidance; assumes comp sales recovery, margin normalization from 22.8%, revenue reacceleration from 0.6-2.8%
• Q3 headline inflated by 536 million one-time gain; adjusted EPS materially weaker
• Capital return pressure: 113% dividend coverage ratio, negative book equity, frozen buyback program
• Operational improvements real: operating income trending up QoQ, deleveraging underway, buybacks redirected to balance sheet repair
• Execution framework: scale out across 94-95 zone and into 96-97 rallies; do not pre-commit to single price at 94.43
• Invalidation level: close above 98 on 200 SMA at 97.94 means broken structure reclaimed
• Catalyst calendar: next CPI print, Q3 earnings in late October/early November, UMich sentiment late October

→ vs aggressive: Multiple compression target of 68-75 (30x to 22-24x) has 'no factual anchor'—'it's a feel' that requires macro to stay at peak hawkishness indefinitely

→ vs aggressive: Position sizing of 30-50% requires three sequential events (rally to resistance, rejection, trend continuation) with materially lower probability than 2:1 headline payoff suggests

→ vs aggressive: MACD histogram flip and RSI at 34.31 not 'weakest form of momentum divergence'—buyers defending lower band and ATR contracting signals coiling, not collapse

→ vs conservative: Pre-committing to execute at 94-95 is 'operationally reasonable but strategically lazy'—leaving 2-4 dollars of improvement on table; Bollinger middle at 96.34 provides better fill potential

→ vs conservative: 14-year dividend growth streak is 'backward looking anchoring bias'—forward question is whether next 14 years resemble last 14 given 113% coverage, negative book equity, frozen buybacks

→ vs conservative: Forward EPS recovery of 3.12 is analyst consensus expectation, not company guidance—it assumes comp sales conversion and margin normalization that market has not validated

→ vs conservative: Both sides overconfident: aggressive overplays multi-quarter compression call; conservative overplays recovery timeline; 'balanced execution is the only defensible path'